Eporise 2000 IU (IV/SC Injection)

2000 IU pre-filled syringe: ৳ 1,000.00

Medicine Details

Category	Details
Generic	Erythropoietin alfa
Company	Ziska pharmaceuticals ltd
Also available as	Eporise 3000 iu injection Eporise 5000 iu injection

Treatment of anemia in Chronic Kidney Disease (CKD) patients on dialysis and not on dialysis
Treatment of anemia in Zidovudine-treated HIV-infected patients
Treatment of anemia in patients undergoing concomitant myelosuppressive chemotherapy
Reduction of allogeneic RBC transfusions in noncardiac, nonvascular surgery patients
Prevention of anemia of prematurity in infants with specific birth weight and gestational age

Recombinant human erythropoietin (EPO) expressed in Chinese hamster ovary cells with a 165 amino acid sequence identical to that of human urinary EPO

Evaluation of Iron Stores and Nutritional Factors before and during treatment
Monitoring hemoglobin levels and adjusting therapy for CKD patients
Recommended starting dose for CKD patients on dialysis and not on dialysis
Dose adjustments for Zidovudine-treated HIV-infected Patients and patients on cancer chemotherapy

Do not shake or use Erythropoietin alfa that has been shaken or frozen
Protect syringe from light
Visual inspection for particulate matter and discoloration prior to administration

Effect may be potentiated by simultaneous therapeutic administration of a haematinic agent

Uncontrolled hypertension
Serious allergic reactions to Erythropoietin alfa
Patients who develop Pure Red Cell Aplasia (PRCA) following treatment with any erythropoietin

Adverse reactions in CKD patients, Zidovudine-treated HIV-infected Patients, Cancer Patients on Chemotherapy, Surgery Patients, and Premature infants

Wide therapeutic margin with potential for causing hemoglobin levels above desired level